Scope
Reference
DACPM2025-51
Description
Procurement of OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack.
Contract 1
Supplier
Contract value
- £4,000,000 excluding VAT
- £4,000,000 including VAT
Above the relevant threshold
Earliest date the contract will be signed
19 January 2026
Contract dates (estimated)
- 19 January 2026 to 31 December 2027
- 1 year, 11 months, 13 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Additional or repeat goods, services or works - extension or partial replacement
These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.
Supplier
LLOYDS CLINICAL LIMITED
- Companies House: 02764914
- Public Procurement Organisation Number: PDZG-6561-CPZD
Unit 4 Scimitar Park, Roydon Road
Harlow
CM19 5GU
United Kingdom
Region: UKH35 - West Essex
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland